US 10308643
Heterocyclic compound
granted A61PA61P21/00A61P25/02
Quick answer
US patent 10308643 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P21/00, A61P25/02, A61P25/28, A61P37/00